Recent advances in JAK inhibitors for the treatment of metabolic syndrome
With an epidemic spread, metabolic syndrome represents an increasingly emerging risk for the population globally, and is currently recognized as a pathological entity. It is represented by a cluster of different conditions including increased blood pressure, high blood sugar, excess body fat around...
Saved in:
Main Authors: | Debora Collotta (Author), Maria Paola Franchina (Author), Virginia Carlucci (Author), Massimo Collino (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery
by: Debora Collotta, et al.
Published: (2023) -
JAK inhibitors: an evidence-based choice of the most appropriate molecule
by: Luca Antonioli, et al.
Published: (2024) -
Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
by: M. Boyadzhiev, et al.
Published: (2019) -
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
by: Amanda Kvist-Hansen, et al.
Published: (2019) -
JAK Inhibitors in Psoriatic Disease
by: Megna M, et al.
Published: (2023)